Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2020-02-25 16:23:05
Reporting Period:
Accepted Time:
2020-02-25 16:23:05
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
200406 Johnson & Johnson JNJ Pharmaceutical Preparations (2834) 221024240
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1768503 Thibaut Mongon One Johnson & Johnson Plaza
New Brunswick NJ 08933
Exec Vp, Ww Chair, Consumer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-02-21 19,224 $90.44 75,039 No 4 M Direct
Common Stock Disposition 2020-02-21 39,224 $147.96 35,815 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Options (Right to Buy) Disposition 2020-02-21 19,224 $0.00 19,224 $90.44
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2018-02-11 2024-02-09 No 4 M Direct
  1. This transaction was executed in multiple trades at prices ranging from $147.59 to $148.37. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  2. Awarded under Issuer's Stock Option Plan and exercisable in full starting one day after the third anniversary of the grant.